Ongoing genomic surveillance shows SARS-CoV-2 continuing to evolve within Omicron lineages, with XFG dominating circulation and prompting routine 2026-2027 vaccine updates rather than triggering a new variant of concern designation. Emerging lineages such as BA.3.2 exhibit immune escape traits yet display limited fitness and have not displaced prevailing strains at scale. WHO tracking emphasizes variants under monitoring over formal concern classifications, reflecting stabilized public health impact and incremental rather than disruptive changes. With only months remaining until the end of 2026, the absence of rapid, high-impact shifts supports trader consensus around a low probability of a new designation before the deadline.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於是
$245,872 交易量
$245,872 交易量
是
$245,872 交易量
$245,872 交易量
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
市場開放時間: Dec 1, 2025, 4:49 PM ET
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Ongoing genomic surveillance shows SARS-CoV-2 continuing to evolve within Omicron lineages, with XFG dominating circulation and prompting routine 2026-2027 vaccine updates rather than triggering a new variant of concern designation. Emerging lineages such as BA.3.2 exhibit immune escape traits yet display limited fitness and have not displaced prevailing strains at scale. WHO tracking emphasizes variants under monitoring over formal concern classifications, reflecting stabilized public health impact and incremental rather than disruptive changes. With only months remaining until the end of 2026, the absence of rapid, high-impact shifts supports trader consensus around a low probability of a new designation before the deadline.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於



警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions